Contact Us
Home Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference

News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference

September 11, 2007
PDF Version

PALO ALTO, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Samuel Saks, M.D., the company's Chief Executive Officer, will provide a corporate presentation at the UBS Life Sciences Conference in New York, NY on September 24, 2007 at 4:00 p.m. Eastern time.

A live webcast of the presentation may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on Jazz Pharmaceuticals' website until October 8, 2007.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

For further information see http://www.JazzPharmaceuticals.com.

SOURCE Jazz Pharmaceuticals, Inc.

CONTACT: Jim Karrels, Executive Director, Finance, of Jazz Pharmaceuticals, Inc.
investorinfo@jazzpharmaceuticals.com
Web site: http://www.jazzpharmaceuticals.com